Cora Capital Advisors LLC Takes $223,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Cora Capital Advisors LLC bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,644 shares of the financial services provider’s stock, valued at approximately $223,000.

A number of other hedge funds have also modified their holdings of IBB. Glass Jacobson Investment Advisors llc increased its position in iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 122 shares during the last quarter. Values First Advisors Inc. acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at about $43,000. Horizon Bancorp Inc. IN purchased a new position in shares of iShares Biotechnology ETF in the third quarter valued at approximately $44,000. Tennessee Valley Asset Management Partners purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $44,000. Finally, Column Capital Advisors LLC purchased a new position in shares of iShares Biotechnology ETF in the third quarter valued at approximately $49,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.7 %

iShares Biotechnology ETF stock traded up $0.82 during trading on Friday, reaching $126.49. The stock had a trading volume of 833,050 shares, compared to its average volume of 1,534,186. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16. The business has a 50 day moving average price of $134.27 and a 200 day moving average price of $129.83.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.